The Hikma Pharmaceuticals Plc Board is recommending a final dividend of 36 cents per share (approximately 26 pence per share) (2020: 34 cents per share) bringing the total dividend for the full year to 54 cents per share (approximately 40 pence per share) (2020: 50 cents per share). The proposed dividend will be paid on 28 April 2022 to eligible shareholders on the register at the close of business on 18 March 2022, subject to approval at the Annual General Meeting on 25 April 2022.
Other financial highlights include:
Group revenue up 9%
Core operating profit up 12%
Core profit attributable to shareholders up 10%
Reported profit attributable to shareholders down 2% and basic EPS was flat
Strong cashflow from operating activities, up 38% to $638 million
